home
sign in
my orders
my e-books
my trolley
my account
contact
keyword
isbn13
author
title
| can't find it |
Tell us the title, author
and / or ISBN number
*
Any other details such as author,
ISBN, title or genre. Please be specific
What is your email address?
*
Not a valid email address
| browse books |
Textbooks
books
antiques & collectibles
architecture
art
biography & autobiography
body, mind & spirit
business & economics
comics & graphic novels
computers
cooking
crafts & hobbies
drama
education
family & relationships
fiction
foreign language study
games
gardening
health & fitness
history
house & home
humor
juvenile fiction
juvenile nonfiction
language arts & disciplines
law
literary collections
literary criticism
mathematics
medical
music
nature
non-classifiable
performing arts
pets
philosophy
photography
poetry
political science
psychology
reference
religion
science
self-help
social science
sports & recreation
study aids
technology
transportation
travel
true crime
books
| book details |
Risk-sharing in the Pharmaceutical Industry: The Case of Out-licensing
By (author)
Gerrit Reepmeyer
| on special |
normal price: R 4 561.95
Price: R 4 332.95
| add to trolley |
processing...
| book description |
The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The consequences are devastating. Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously. Particularly if a company is highly dependent on just a handful of mega-selling blockbuster drugs, the risks can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical companies have started to organize their R&D in partnership. In fact, more than 600 alliances in pharmaceutical R&D are signed every year.
| product details |
Normally shipped |
Available from overseas. Usually dispatched in 14 days
Publisher |
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Published date |
5 Dec 2005
Language |
Format |
Paperback / softback
Pages |
297
Dimensions |
235 x 155 x 0mm (L x W x H)
Weight |
0g
ISBN |
978-3-7908-1667-9
Readership Age |
BISAC |
business & economics / industries / manufacturing industries
| other options |
| back |
| your trolley |
To view the items in your trolley please sign in.
| sign in |
| specials |
The Memory Collectors: A Novel
Dete Meserve
Paperback / softback
320 pages
Enquiries only
| more |
| enquire |
processing...
Survive the AI Apocalypse: A guide for solutionists
Bronwyn Williams
Paperback / softback
232 pages
was: R 340.95
now: R 306.95
Stock is usually dispatched in 6-12 days from date of order
Look around you is anything real or normal any more? News, images and videos created by AI are everywhere.
| more |
| add to trolley |
processing...
The Colonialist: The Vision of Cecil Rhodes
William Kelleher Storey
Paperback / softback
528 pages
was: R 425.95
now: R 382.95
Usually dispatched in 6-12 days
This first comprehensive biography of Cecil Rhodes in a generation illuminates Rhodes’s vision for the expansion of imperialism in southern Africa, connecting politics and industry to internal development, and examines how this fueled a lasting, white-dominated colonial society.
| more |
| add to trolley |
processing...
The Coming Wave: AI, Power and Our Future
Mustafa Suleyman
Paperback / softback
352 pages
was: R 295.95
now: R 265.95
Stock is usually dispatched in 6-12 days from date of order
| more |
| add to trolley |
processing...
Copyright 2025
|
terms and conditions